Single-cell transcriptomics and network pharmacology reveal therapeutic targets of Jianpi Yiqi Bugan Yishen decoction in immune cell subsets of children with myasthenia gravis.

Liu, Peng; Qi, Guoyan; Gu, Shanshan; Dong, Huimin; Liu, Chaoying; Yang, Hongxia

Liu, Peng; Qi, Guoyan; Gu, Shanshan; Dong, Huimin; Liu, Chaoying; Yang, Hongxia.

Afiliación

Liu P; Center of Treatment of Myasthenia Gravis, People's Hospital of Shijiazhuang Affiliated to Hebei Medical University, Shijiazhuang, China.
Qi G; Hebei Provincial Key Laboratory of Myasthenia Gravis, Shijiazhuang, China.
Gu S; Center of Treatment of Myasthenia Gravis, People's Hospital of Shijiazhuang Affiliated to Hebei Medical University, Shijiazhuang, China.
Dong H; Hebei Provincial Key Laboratory of Myasthenia Gravis, Shijiazhuang, China.
Liu C; Hebei Provincial Clinical Research Center for Myasthenia Gravis, Shijiazhuang, China.
Yang H; Center of Treatment of Myasthenia Gravis, People's Hospital of Shijiazhuang Affiliated to Hebei Medical University, Shijiazhuang, China.

Transl Pediatr ; 11(12): 1985-2003, 2022 Dec.

Article en En | MEDLINE | ID: mdl-36643680

Palabras clave

Jianpi Yiqi Bugan Yishen Decoction (JYBYD); Traditional Chinese medicine (TCM); cortactin; myasthenia gravis (MG)

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Transl Pediatr Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google